Cycling and Virtual Reality for Multiple Sclerosis
(PACE-MS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how cycling with and without virtual reality affects thinking speed in individuals with multiple sclerosis (MS). Participants will either cycle alone, cycle while engaging with a virtual reality task, or cycle with a visual virtual reality experience. The goal is to determine which method best aids mental processing. Known as PACE-MS, this trial seeks individuals who have MS, speak English, have mild-to-moderate mobility issues, have been free of relapses and steroids for the past 30 days, and are not currently regular cyclists.
As an unphased study, this trial provides a unique opportunity to contribute to innovative research that could enhance mental processing for those with MS.
Will I have to stop taking my current medications?
The trial requires that you do not use medications that may impact cognition, such as steroids or benzodiazepines. If you are taking these, you may need to stop before participating.
What prior data suggests that these cycling and virtual reality methods are safe for people with multiple sclerosis?
Research shows that both cycling and virtual reality (VR) are generally safe for people with multiple sclerosis (MS). Studies have found that immersive VR is safe, with most people experiencing no major problems. However, some might feel cybersickness, similar to motion sickness.
When cycling with VR that includes cognitive tasks, people with MS find it beneficial for rehabilitation. This type of VR requires thinking while cycling, and many find it fun and engaging.
Cycling with VR that simply displays a virtual environment is also safe and feasible. It can make exercise more enjoyable and help people exercise longer.
In both cases, VR offers a safe and enjoyable way to increase physical activity and improve cognitive skills in people with MS. As always, individuals should consider their health and consult their doctor before starting new exercises.12345Why are researchers excited about this trial?
Researchers are excited about using cycling combined with virtual reality (VR) for multiple sclerosis (MS) because it offers a unique way to engage both the body and the mind, which is different from traditional drug therapies like interferons and glatiramer acetate. The approach combines physical exercise with either cognitively or visually stimulating VR, potentially enhancing cognitive functions while improving physical fitness. This dual-action strategy might not only help with mobility but also boost mental agility, offering a comprehensive benefit that standard MS treatments don't typically address. By integrating VR, the treatments aim to make exercise more engaging and possibly more effective, which could lead to improved outcomes for people with MS.
What evidence suggests that this trial's treatments could be effective for multiple sclerosis?
Studies have shown that both cycling and virtual reality (VR) can enhance physical and mental abilities in people with multiple sclerosis (MS). This trial will compare different approaches: one group will engage in cycling alone, while others will participate in cycling with either cognitively stimulating VR or visually stimulating VR. Research indicates that VR might enhance traditional exercise and cognitive training for those with MS. Specifically, VR-based therapy reduced fatigue more effectively than standard treatments. Another study found that VR improved balance and lessened the fear of falling. Overall, these findings suggest that combining VR with cycling might improve thinking speed and other skills in people with MS.12678
Who Is on the Research Team?
Carly Wender, PhD
Principal Investigator
Kessler Foundation
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals with a confirmed MS diagnosis by a neurologist, who have been free of relapses and steroids for at least 30 days, and report moderate mobility disability. It excludes those with other neurological disorders or uncontrolled psychiatric conditions, contraindications to exercise, cognition-impacting medications use (like steroids), current pregnancy, severe cognitive impairment, high motion sickness likelihood or regular cyclists.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete three cycling conditions: cycling alone, cycling with cognitively stimulating VR, and cycling with visually stimulating VR, one per week.
Follow-up
Participants are monitored for processing speed improvements after each cycling session.
What Are the Treatments Tested in This Trial?
Interventions
- PACE-MS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kessler Foundation
Lead Sponsor
Consortium of Multiple Sclerosis Centers
Collaborator